Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer

Completed · Phase 3

Conditions studied: Colorectal Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if irinotecan is more effective with or without oxaliplatin in treating metastatic colorectal cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of irinotecan with or without oxaliplatin in treating patients who have metastatic colorectal cancer.

Key facts

Study ID

NCT00012389

Run by

Sanofi

Starts

2000-12-01

Expected to finish

2008-10-01

Last updated by the study team

2013-12-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Oncology Center at Providence Park — Mobile, Alabama, United States
• Arizona Clinical Research Center — Tucson, Arizona, United States
• Citrus Valley Medical Center — Covina, California, United States
• California Cancer Care, Inc. — Greenbrae, California, United States
• Tower Hematology Oncology Medical Group — Los Angeles, California, United States
• Kenmar Research Institute — Los Angeles, California, United States
• Study site — Los Angeles, California, United States
• Medical Oncology Care Associates — Orange, California, United States
• P.M.K. Medical Group, Inc. — Oxnard, California, United States
• Cancer and Blood Institute of the Desert — Rancho Mirage, California, United States
• Kaiser Permanente-Southern California Permanente Medical Group — San Diego, California, United States
• John Wayne Cancer Institute — Santa Monica, California, United States
• Kaiser Permanente Medical Center - Vallejo — Vallejo, California, United States
• Colorado Permanente Medical Group, P.C. — Denver, Colorado, United States
• Rocky Mountain Cancer Center — Denver, Colorado, United States
• University of Colorado Cancer Center — Denver, Colorado, United States
• Whittingham Cancer Center — Norwalk, Connecticut, United States
• George Washington University Medical Center — Washington D.C., District of Columbia, United States
• Comprehensive Cancer Care Specialists of Boca Raton — Boca Raton, Florida, United States
• Center for Hematology-Oncology — Boca Raton, Florida, United States
• Southeast Florida Hematology-Oncology Group — Fort Lauderdale, Florida, United States
• Florida Cancer Specialists — Fort Myers, Florida, United States
• Shands Hospital and Clinics, University of Florida — Gainesville, Florida, United States
• Hematology and Oncology Associates of Jacksonville — Jacksonville, Florida, United States
• Comprehensive Cancer Institute of Huntsville — Huntsville, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.